Is nicotinamide adenine dinucleotide (NAD⁺) available in oral form?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is NAD+ Available in Oral Form?

NAD+ itself is not available as an effective oral supplement, but oral NAD+ precursors—particularly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—are available and effectively raise blood NAD+ levels in humans. 1, 2, 3

Why Direct NAD+ Oral Supplementation Is Not Used

  • NAD+ is a large, charged molecule that does not cross cell membranes efficiently when taken orally 4
  • The established clinical approach uses NAD+ precursors rather than NAD+ itself 1, 2, 3
  • Guidelines recommend oral/enteral routes for niacin (vitamin B3) supplementation whenever the gastrointestinal tract is functional 2, 3

Effective Oral NAD+ Precursors

Nicotinamide Riboside (NR)

  • NR is orally bioavailable and produces dose-dependent increases in blood NAD+ levels in humans 5
  • Single oral doses of 100,300, and 1,000 mg of NR produce measurable increases in the blood NAD+ metabolome 5
  • NR can raise human blood NAD+ levels up to 2.7-fold with a single oral dose 5
  • NR has superior pharmacokinetics compared to nicotinic acid and nicotinamide for elevating hepatic NAD+ 5

Nicotinamide Mononucleotide (NMN)

  • Oral NMN supplementation at 250 mg/day for 12 weeks significantly increases NAD+ levels in whole blood with no adverse effects 6
  • NMN is safe and well-tolerated in healthy human subjects 6
  • The increased NAD+ from NMN correlates with baseline pulse rate, suggesting individual variability in response 6

Reduced Nicotinamide Riboside (NRH)

  • NRH acts as a more potent and faster NAD+ precursor than NR in mammalian cells and tissues 7
  • NRH is orally bioavailable in mice and uses a different, NRK1-independent pathway for NAD+ synthesis 7

Standard Niacin Forms (Nicotinic Acid and Nicotinamide)

  • The American College of Nutrition recommends daily niacin intake: 16 mg/day for adult males, 14 mg/day for adult females 1, 3
  • Nicotinamide has a favorable safety profile with an upper limit of approximately 900 mg/day for adults 2, 3
  • Nicotinic acid has a much lower upper safety limit (10 mg/day for free nicotinic acid) due to flushing effects 2, 3

Clinical Evidence for Oral NAD+ Precursor Supplementation

  • Oral supplementation with NAD+ precursors is safe, tolerable, and increases NAD+ abundance in multiple tissues 8
  • Studies demonstrate improvements in quality of life, decreased anxiety, reduced maximum heart rate after stress testing, and increased muscle insulin sensitivity 9
  • Common side effects are mild and include muscle pain, nervous disorders, fatigue, sleep disturbance, and headaches—none presenting serious health risks 9

Practical Recommendations

First-Line Approach

  • Recommend dietary sources of niacin: meat, poultry, fish (especially tuna and salmon), nuts, legumes, whole-grain cereals, and dark-green leafy vegetables 2, 3

If Supplementation Is Desired

  • Use nicotinamide riboside (100-1,000 mg/day) or nicotinamide mononucleotide (250 mg/day) for NAD+ boosting 6, 5
  • Standard nicotinamide (up to 900 mg/day) is also effective and has established safety data 3

Monitoring

  • Baseline and periodic hepatic transaminases (ALT, AST) every 6 months when using doses approaching or exceeding 1,000 mg daily 3
  • Discontinue if transaminases exceed 2-3 times the upper limit of normal 3
  • Baseline fasting glucose or hemoglobin A1c to monitor metabolic effects 3

Critical Caveat: Avoid Injectable NAD+

  • Injectable NAD+ is not FDA-approved and is not recommended in any clinical practice guidelines 1, 2
  • Injectable administration bypasses protective barriers and introduces infection risk, hypersensitivity reactions, and unknown pharmacokinetics 1
  • No standardized dosing protocols exist for injectable NAD+ 1

References

Guideline

NAD+ Injectable Administration: Safety and Regulatory Status

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

NAD Infusion in Humans: Current Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

NAD+ Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.

The journals of gerontology. Series A, Biological sciences and medical sciences, 2023

Research

Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.

American journal of physiology. Endocrinology and metabolism, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.